Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV

Virology

Volumn 364, Issue 2, 2007, Pages 422-430

  Perez Filgueira D M ^a,c   Resino Talavan P ^a   Cubillos, C ^b   Angulo, I ^b   Barderas, M G ^a   Barcena, J ^b   Escribano, J M ^a  

^a INIA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

Baculovirus; Calicivirus; Insect expression system; Larvae; Low cost; Recombinant vaccine; RHDV

Indexed keywords

CAPSID PROTEIN; PROTEIN SUBUNIT; RECOMBINANT ANTIGEN; VIRUS VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTHROPOD LARVA; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG SAFETY; DRUG SCREENING; DRUG STABILITY; FREEZE DRYING; IMMUNOGENETICS; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; ROOM TEMPERATURE; SINGLE DRUG DOSE; VIRUS HEMORRHAGIC FEVER;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BACULOVIRIDAE; CALICIVIRIDAE INFECTIONS; COSTS AND COST ANALYSIS; HEMORRHAGIC DISEASE VIRUS, RABBIT; INJECTIONS, INTRAMUSCULAR; LARVA; MOTHS; RABBITS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

ANIMALIA; CALICIVIRIDAE; HEXAPODA; MIRIDAE; ORYCTOLAGUS CUNICULUS; RABBIT HEMORRHAGIC DISEASE VIRUS; TRICHOPLUSIA NI;

EID: 34249876374     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.03.016     Document Type: Article

References (54)

1. Ahmad S., Bassiri M., Banerjee A.K., and Yilma T. Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in Spodoptera exigua larva: use in differential diagnosis between vaccinated and infected animals. Virology 192 (1993) 207-216
2. Argüello-Villares J.L. Viral haemorrhagic disease virus of rabbits: vaccination and immune response. Rev. Sci. Tech. - Off. Int. Épizoot. 10 (1991) 471-480
3. Bahnemann H.G. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8 (1990) 299-303
4. Barcena J., Morales M., Vazquez B., Boga J.A., Parra F., Lucientes J., Pages-Mante A., Sanchez-Vizcaino J.M., Blasco R., and Torres J.M. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. J. Virol. 74 (2000) 1114-1123
5. Barcena J., Verdaguer N., Roca R., Morales M., Angulo I., Risco C., Carrascosa J.L., Torres J.M., and Caston J.R. The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. Virology 322 (2004) 118-134
6. Barderas M.G., Rodriguez F., Gomez-Puertas P., Aviles M., Beitia F., Alonso C., and Escribano J.M. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch. Virol. 146 (2001) 1681-1691
7. Bertagnoli S., Gelfi J., Le Gall G., Boilletot E., Vautherot J.F., Rasschaert D., Laurent S., Petit F., Boucraut-Baralon C., and Milon A. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J. Virol. 70 (1996) 5061-5066
8. Bertagnoli S., Gelfi J., Petit F., Vautherot J.F., Rasschaert D., Laurent S., Le Gall G., Boilletot E., Chantal J., and Boucraut-Baralon C. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine 14 (1996) 506-510
9. Boga J.A., Casais R., Marin M.S., Martin-Alonso J.M., Carmenes R.S., Prieto M., and Parra F. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J. Gen. Virol. 75 Pt. 9 (1994) 2409-2413
10. Boga J.A., Martin Alonso J.M., Casais R., and Parra F. A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection. J. Gen. Virol. 78 Pt. 9 (1997) 2315-2318
11. Bouslama A., De Mia G.M., Hammami S., Aouina T., Soussi H., and Frescura T. Identification of the virus of rabbit haemorrhagic disease in Tunisia. Vet. Rec. 138 (1996) 108-110
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
13. Castanon S., Marin M.S., Martin-Alonso J.M., Boga J.A., Casais R., Humara J.M., Ordas R.J., and Parra F. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. Virol. 73 (1999) 4452-4455
14. Choi J.Y., Woo S.D., Lee H.K., Hong H.K., Je Y.H., Park J.H., Song J.Y., An S.H., and Kang S.K. High-level expression of canine parvovirus VP2 using Bombyx mori nucleopolyhedrovirus vector. Arch. Virol. 145 (2000) 171-177
15. Farnos O., Boue O., Parra F., Martin-Alonso J.M., Valdes O., Joglar M., Navea L., Naranjo P., and Lleonart R. High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris. J. Biotechnol. 117 (2005) 215-224
16. Fernandez-Fernandez M.R., Mourino M., Rivera J., Rodriguez F., Plana-Duran J., and Garcia J.A. Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology 280 (2001) 283-291
17. Fischer L., Le Gros F.X., Mason P.W., and Paoletti E. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine 15 (1997) 90-96
18. Gil F., Titarenko E., Terrada E., Arcalis E., and Escribano J.M. Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies. Plant Biotechnol. J. 4 (2006) 135-143
19. Granzow H., Weiland F., Strebelow H.G., Liu C.M., and Schirrmeier H. Rabbit hemorrhagic disease virus (RHDV): ultrastructure and biochemical studies of typical and core-like particles present in liver homogenates. Virus Res. 41 (1996) 163-172
20. Gregg D.A., House C., Meyer R., and Berninger M. Viral haemorrhagic disease of rabbits in Mexico: epidemiology and viral characterization. Rev. Sci. Tech. 10 (1991) 435-451
21. Gromadzka B., Szewczyk B., Konopa G., Fitzner A., and Kesy A. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus. Acta Biochim. Pol. 53 (2006) 371-376
22. Ismail T.M., Yamanaka M.K., Saliki J.T., el-Kholy A., Mebus C., and Yilma T. Cloning and expression of the nucleoprotein of peste des petits ruminants virus in baculovirus for use in serological diagnosis. Virology 208 (1995) 776-778
23. Jiang X., Zhong W.M., Farkas T., Huang P.W., Wilton N., Barrett E., Fulton D., Morrow R., and Matson D.O. Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses. Arch. Virol. 147 (2002) 119-130
24. Johansson B.E., Price P.M., and Kilbourne E.D. Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine 13 (1995) 841-845
25. Katz J.B., Shafer A.L., and Eernisse K.A. Construction and insect larval expression of recombinant vesicular stomatitis nucleocapsid protein and its use in competitive ELISA. J. Virol. Methods 54 (1995) 145-157
26. Laurent S., Vautherot J.F., Madelaine M.F., Le Gall G., and Rasschaert D. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J. Virol. 68 (1994) 6794-6798
27. Liu S.J., Xue H.P., Pu B.Q., and Qian N. A new viral disease in rabbits. Animal Husbandry and Veterinary Medicine 16 (1984) 253-255
28. Maeda S., Kawai T., Obinata M., Fujiwara H., Horiuchi T., Saeki Y., Sato Y., and Furusawa M. Production of human alpha-interferon in silkworm using a baculovirus vector. Nature 315 (1985) 592-594
29. Marin M.S., Martin Alonso J.M., Perez Ordoyo Garcia L.I., Boga J.A., Arguello-Villares J.L., Casais R., Venugopal K., Jiang W., Gould E.A., and Parra F. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine. Virus Res. 39 (1995) 119-128
30. Martin-Alonso J.M., Castanon S., Alonso P., Parra F., and Ordas R. Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein. Transgenic Res. 12 (2003) 127-130
31. Martinez-Torrecuadrada J.L., Cortes E., Vela C., Langeveld J.P., Meloen R.H., Dalsgaard K., Hamilton W.D., and Casal J.I. Antigenic structure of the capsid protein of rabbit haemorrhagic disease virus. J. Gen. Virol. 79 Pt. 8 (1998) 1901-1909
32. Mathavan S., Gautvik V.T., Rokkones E., Olstad O.K., Kareem B.N., Maeda S., and Gautvik K.M. High-level production of human parathyroid hormone in Bombyx mori larvae and BmN cells using recombinant baculovirus. Gene 167 (1995) 33-39
33. Matsuoka H., Kobayashi J., Barker G.C., Miura K., Chinzei Y., Miyajima S., Ishii A., and Sinden R.E. Induction of anti-malarial transmission blocking immunity with a recombinant ookinete surface antigen of Plasmodium berghei produced in silkworm larvae using the baculovirus expression vector system. Vaccine 14 (1996) 120-126
34. Medin J.A., Hunt L., Gathy K., Evans R.K., and Coleman M.S. Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2760-2764
35. Mitro S., and Krauss H. Rabbit hemorrhagic disease: a review with special reference to its epizootiology. Eur. J. Epidemiol. 9 (1993) 70-78
36. Molina A., Veramendi J., and Hervas-Stubbs S. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342 (2005) 266-275
37. Moss S.R., Turner S.L., Trout R.C., White P.J., Hudson P.J., Desai A., Armesto M., Forrester N.L., and Gould E.A. Molecular epidemiology of Rabbit haemorrhagic disease virus. J. Gen. Virol. 83 (2002) 2461-2467
38. Muneta Y., Nagaya H., Minagawa Y., Enomoto C., Matsumoto S., and Mori Y. Expression and one-step purification of bovine interleukin-21 (IL-21) in silkworms using a hybrid baculovirus expression system. Biotechnol. Lett. 26 (2004) 1453-1458
39. Nagaya H., Muneta Y., Enomoto C., Matsumoto S., Yokomizo Y., and Mori Y. Method for purifying porcine mature interleukin-18 from silkworm haemolymph. Biotechnol. Lett. 26 (2004) 869-873
40. Nagesha H.S., Wang L.F., Hyatt A.D., Morrissy C.J., Lenghaus C., and Westbury H.A. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Arch. Virol. 140 (1995) 1095-1108
41. Office International des Epizooties (OIE). Rabbit haemorrhagic disease in Uruguay. Dis. Inf. 17 (2004) 401-402
42. Ohlinger V.F., Haas B., Meyers G., Weiland F., and Thiel H.J. Identification and characterization of the virus causing rabbit hemorrhagic disease. J. Virol. 64 (1990) 3331-3336
43. O'Reilly D.R., Miller L.K., and Luckow V.A. Baculovirus Expression Vectors: A Laboratory Manual (1992), W. H. Freeman & Co., New York
44. Oviedo J.M., Rodriguez F., Gomez-Puertas P., Brun A., Gomez N., Alonso C., and Escribano J.M. High level expression of the major antigenic African swine fever virus proteins p54 and p30 in baculovirus and their potential use as diagnostic reagents. J. Virol. Methods 64 (1997) 27-35
45. Pang A.L., Hashimoto C.N., Tam L.Q., Meng Z.Q., Hui G.S., and Ho W.K. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system. Infect. Immun. 70 (2002) 2772-2779
46. Park J.H., Kida H., Ueda K., Ochiai K., Goryo M., and Itakura C. Etiology of rabbit haemorrhagic disease spontaneously occurring in Korea. Zentralbl. Veterinarmed. B 38 (1991) 749-754
47. Parra F., and Prieto M. Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J. Virol. 64 (1990) 4013-4015
48. Perez-Filgueira D.M., Gonzalez-Camacho F., Gallardo C., Resino-Talavan P., Blanco E., Gomez-Casado E., Alonso C., and Escribano J.M. Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J. Clin. Microbiol. 44 (2006) 3114-3121
49. Plana-Duran J., Bastons M., Rodriguez M.J., Climent I., Cortes E., Vela C., and Casal I. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch. Virol. 141 (1996) 1423-1436
50. Ramiro-Ibanez F., Martin-Alonso J.M., Garcia Palencia P., Parra F., and Alonso C. Macrophage tropism of rabbit hemorrhagic disease virus is associated with vascular pathology. Virus Res. 60 (1999) 21-28
51. Reis U., Blum B., von Specht B.U., Domdey H., and Collins J. Antibody production in silkworm cells and silkworm larvae infected with a dual recombinant Bombyx mori nuclear polyhedrosis virus. Biotechnology (NY) 10 (1992) 910-912
52. Sumathy S., Palhan V.B., and Gopinathan K.P. Expression of human growth hormone in silkworm larvae through recombinant Bombyx mori nuclear polyhedrosis virus. Protein Expr. Purif. 7 (1996) 262-268
53. Ueda K., Park J.H., Ochiai K., and Itakura C. Disseminated intravascular coagulation (DIC) in rabbit haemorrhagic disease. Jpn. J. Vet. Res. 40 (1992) 133-141
54. Zhou N., Zhang Y., Jing W., Li Z., and Wu X. High expression of HBV S gene in Bombyx mori cell culture and in silkworms. Chin. J. Biotechnol. 11 (1995) 149-156